Potential for false-positive staining with a rabbit monoclonal antibody to progesterone receptor (SP2): findings of the UK National External Quality Assessment Scheme for Immunocytochemistry and FISH highlight the need for correct validation of antibodies on introduction to the laboratory.
暂无分享,去创建一个
B. Jasani | M. Ibrahim | A. Dodson | D. Fish | K. Miller | Sarah Barnett | S. Barnett
[1] B. Jasani,et al. Technical aspects of predictive and prognostic markers in breast cancer: What UK NEQAS data shows , 2007 .
[2] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.
[3] R. Elledge,et al. Molecular markers for predicting response to tamoxifen in breast cancer patients , 2000, Endocrine.
[4] M. Dowsett. Estrogen receptor: methodology matters. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Karen A Gelmon,et al. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Zhida Huang,et al. Development of New Rabbit Monoclonal Antibody to Progesterone Receptor (Clone SP2): No Heat Pretreatment but Effective for Paraffin Section Immunohistochemistry , 2006, Applied immunohistochemistry & molecular morphology : AIMM.
[7] R. Schiff,et al. Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy. , 2005, Breast.
[8] Adrian V. Lee,et al. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] M. Begnami,et al. Antigen Retrieval Methods and Estrogen Receptor Immunoexpression Using 1D5 Antibody: A Comparative Study , 2005, International journal of surgical pathology.
[10] A. D. Dei Tos,et al. Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies. , 2005, American journal of clinical pathology.
[11] G. Szekeres,et al. Development of New Rabbit Monoclonal Antibody to Estrogen Receptor: Immunohistochemical Assessment on Formalin-Fixed, Paraffin-Embedded Tissue Sections , 2005, Applied immunohistochemistry & molecular morphology : AIMM.
[12] J. Chan,et al. Consistent Immunostaining for Cyclin D1 Can Be Achieved on a Routine Basis Using a Newly Available Rabbit Monoclonal Antibody , 2004, The American journal of surgical pathology.
[13] L. Bobrow,et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. , 2001, American journal of clinical pathology.
[14] K L Knight,et al. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] C. Redmond,et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. , 1989, The New England journal of medicine.